Skip to content

Advertisement

Open Peer Review Reports for: A randomized controlled double blind trial comparing the effects of the prophylactic antibiotic, Cefazolin, administered at caesarean delivery at two different timings (before skin incision and after cord clamping) on both the mother and newborn

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
3 Feb 2016 Submitted Original manuscript
25 Feb 2016 Author responded Author comments - Chinta Jyothirmayi
Resubmission - Version 2
25 Feb 2016 Submitted Manuscript version 2
3 Jun 2016 Reviewed Reviewer Report - Mahmoud Ahmed Mahmoud Abdel-Alee
16 Jun 2016 Reviewed Reviewer Report - Elizabeth Moore
30 Jun 2016 Reviewed Reviewer Report - Scott A Sullivan
3 Jan 2017 Author responded Author comments - Chinta Jyothirmayi
Resubmission - Version 3
3 Jan 2017 Submitted Manuscript version 3
22 Jan 2017 Reviewed Reviewer Report - Scott A Sullivan
29 Jan 2017 Reviewed Reviewer Report - Elizabeth Moore
21 May 2017 Author responded Author comments - Chinta Jyothirmayi
Resubmission - Version 4
21 May 2017 Submitted Manuscript version 4
18 Jun 2017 Reviewed Reviewer Report - Elizabeth Moore
26 Jun 2017 Reviewed Reviewer Report - Scott A Sullivan
11 Jul 2017 Author responded Author comments - Chinta Jyothirmayi
Resubmission - Version 5
11 Jul 2017 Submitted Manuscript version 5
17 Sep 2017 Author responded Author comments - Chinta Jyothirmayi
Resubmission - Version 6
17 Sep 2017 Submitted Manuscript version 6
Publishing
20 Sep 2017 Editorially accepted
3 Oct 2017 Article published 10.1186/s12884-017-1526-y

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement